Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05932914 · ClinicalTrials.gov registry record
Liver Biopsy Following Gene Therapy For Hemophilia
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Not yet
- Registry status
- 8
- Enrollment target
NCT05932914: Clinical Trial study, sponsored by St. Jude Children's Research Hospital.
NCT05932914 is a clinical trial that has not yet begun recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05932914 has not yet begun recruiting, sponsored by St. Jude Children's Research Hospital.
- NOT YET RECRUITING
- Registry status
- 8 participants
- Enrollment target
Study Summary
This observational study will obtain liver biopsy samples and evaluate the long-term effect of adeno-associated virus (AAV)-mediated gene therapy on the liver tissue in adult patients with hemophilia A or hemophilia B who have previously been treated with a factor VIII or factor IX gene-containing AAV-vector for liver-targeted gene transfer. Participants are from a cohort of patients treated with AAV-mediated gene transfer and at least 6 months after vector infusion.
Primary Outcome
Fluorescence in situ hybridization (FISH)
Interventions
- PROCEDURE Liver Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-01 |
What is known before NCT05932914 opens enrollment
NCT05932914 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Liver Biopsy is the first listed.
NCT05932914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05932914 about?
NCT05932914 is a clinical study titled "Liver Biopsy Following Gene Therapy For Hemophilia". This observational study will obtain liver biopsy samples and evaluate the long-term effect of adeno-associated virus (AAV)-mediated gene therapy on the liver tissue in adult patients with hemophilia A or hemophilia B who have previously been treated with a factor VIII or factor IX gene-containing A...
What is the current status of trial NCT05932914?
This trial is currently not yet recruiting. The enrollment target is 8 participants. The study started on 2026-07. Estimated completion is 2030-01.
What interventions are being tested in trial NCT05932914?
The interventions under investigation include: Liver Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05932914?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia